ArticleTranslational andrology and urology2025
Testosterone threshold, assay and costs among laboratories for hypogonadism diagnosis.
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The diagnosis of testosterone deficiency (hypogonadism) requires documentation of low testosterone concentration. Despite the thresholds for low testosterone established by various guidelines, non-expert physicians rely on reference ranges provided by laboratories. The objective of this study was to determine the consistency of laboratory-established reference ranges for total testosterone (TT) among Mexico City clinical laboratories. Methods: Information was requested from 202 laboratories in Mexico City in August 2024. The items of interest included the TT reference ranges, equipment, assays, and costs. Results: The responses were obtained from 134 laboratories. There were 27 different sets of reference ranges used in this study. The high TT threshold ranged from 400 to 1,719 ng/dL (variability: 487%), whereas the lower limit ranged from 84 to 470 ng/dL (variability: 426%). Five measurement methods were described, and the most frequently used was chemiluminescence 69 (51.11%), followed by electrochemiluminescence 25 (18.65%). The cost ranged from $9-160 USD, with a mean of $35 USD. Conclusions: The extreme variability in laboratory-established TT reference ranges represents a major challenge for the appropriate diagnosis and management of men with symptomatic testosterone deficiency. Although these results were obtained in Mexico City, there is good reason to believe that this problem exists globally.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.